Charles River Laboratories International, Inc.

CRL Stock Healthcare Medical - Diagnostics & Research
$291.50
-4.91 (-1.66%)
Price as of Aug 28, 2026 market close

Performance

1 Month
+24.2%
3 Months
+61.3%
YTD
+46.1%
1 Year
+79.1%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
45.7%
Largest decline max drawdown, since Aug 2025
-33.9%
Risk-adjusted return Sharpe ratio, 1-year
1.50

Own CRL?

See how CRL contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.